273 related articles for article (PubMed ID: 21154820)
21. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs and future therapeutic applications in cancer.
Casalini P; Iorio MV
J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
[TBL] [Abstract][Full Text] [Related]
23. SnapShot: MicroRNAs in Cancer.
Spizzo R; Nicoloso MS; Croce CM; Calin GA
Cell; 2009 May; 137(3):586-586.e1. PubMed ID: 19410551
[No Abstract] [Full Text] [Related]
24. MicroRNAs and cancer--new paradigms in molecular oncology.
Negrini M; Nicoloso MS; Calin GA
Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
Wang Y; Liang Y; Lu Q
Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
[TBL] [Abstract][Full Text] [Related]
26. Micromarkers: miRNAs in cancer diagnosis and prognosis.
Ferracin M; Veronese A; Negrini M
Expert Rev Mol Diagn; 2010 Apr; 10(3):297-308. PubMed ID: 20370587
[TBL] [Abstract][Full Text] [Related]
27. Noncoding RNAs in molecular characterization of cancer preneoplasia.
Wang W; Srivastava S
Cancer Biomark; 2010; 9(1-6):133-40. PubMed ID: 22112473
[TBL] [Abstract][Full Text] [Related]
28. The role of microRNAs in colorectal cancer.
Liu M; Chen H
J Genet Genomics; 2010 Jun; 37(6):347-58. PubMed ID: 20621017
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in tumorigenesis: a primer.
Zhang W; Dahlberg JE; Tam W
Am J Pathol; 2007 Sep; 171(3):728-38. PubMed ID: 17724137
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
Nana-Sinkam SP; Croce CM
IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
[TBL] [Abstract][Full Text] [Related]
31. SiLEncing SLE: the power and promise of small noncoding RNAs.
Rigby RJ; Vinuesa CG
Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
[TBL] [Abstract][Full Text] [Related]
32. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
33. siRNA and miRNA for the treatment of cancer.
Jankovic R; Radulovic S; Brankovic-Magic M
J BUON; 2009 Sep; 14 Suppl 1():S43-9. PubMed ID: 19785069
[TBL] [Abstract][Full Text] [Related]
34. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer.
Kanellopoulou C; Monticelli S
Semin Cancer Biol; 2008 Apr; 18(2):79-88. PubMed ID: 18291671
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
36. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
Song B; Ju J
Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
Wei J; Xie L; Taron M; Rosell R; Liu B
Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
[TBL] [Abstract][Full Text] [Related]
38. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs in common diseases and potential therapeutic applications.
Tsai LM; Yu D
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):102-7. PubMed ID: 19671070
[TBL] [Abstract][Full Text] [Related]
40. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.
Kasinski AL; Slack FJ
Curr Opin Mol Ther; 2010 Apr; 12(2):147-57. PubMed ID: 20373258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
